Craig Tooman
Directeur Général chez SILENCE THERAPEUTICS PLC
Fortune : 82 460 $ au 31/05/2024
Profil
Craig Allen Tooman is the founder of Stockbourne LLC, which was founded in 2011.
He held the title of Principal during his time there.
Mr. Tooman's current jobs include President, CEO & Executive Director at Silence Therapeutics Plc, Independent Non-Executive Director at Ondine Biomedical, Inc., Director at Silence Therapeutics, Inc., Director at Verte Therapeutics LLC, Member-Supervisory Board at CureVac SE, and Member-Supervisory Board at CureVac NV.
Mr. Tooman's former jobs include President, Chief Executive Officer & Director at Aratana Therapeutics, Inc., Chief Executive Officer at Avanzar Medical, Inc., Independent Director at InSite Vision, Inc., Director at Xanodyne Pharmaceuticals, Inc., Director at Aratana Therapeutics NV, Chief Operating & Financial Officer, Director at Vyome Therapeutics, Inc., Director at Vet Therapeutics, Inc., Director at ViroVet NV, Chief Financial Officer, Executive VP & Head-IR at Enzon Pharmaceuticals, Inc., Vice President-Investor Relations at Pharmacia & Upjohn, Inc., SVP-Strategic Planning & Corporate Communications at ILEX Oncology, Inc., and Chief Financial Officer & Senior Vice President at Ikaria, Inc.
Mr. Tooman's education includes an MBA from The University of Chicago and an undergraduate degree from Kalamazoo College.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CUREVAC N.V.
0,00% | 15/03/2024 | 9 653 ( 0,00% ) | 37 550 $ | 31/05/2024 |
SILENCE THERAPEUTICS PLC
0,03% | 01/03/2024 | 33 486 ( 0,03% ) | 29 468 $ | 31/07/2023 |
ONDINE BIOMEDICAL, INC.
0,09% | 05/12/2023 | 173 278 ( 0,09% ) | 15 443 $ | 31/05/2024 |
Postes actifs de Craig Tooman
Sociétés | Poste | Début |
---|---|---|
CUREVAC N.V. | Directeur/Membre du Conseil | 01/06/2019 |
SILENCE THERAPEUTICS PLC | Directeur Général | 21/02/2022 |
ONDINE BIOMEDICAL INC. | Directeur/Membre du Conseil | 07/12/2021 |
Silence Therapeutics, Inc. | Directeur/Membre du Conseil | 01/01/2021 |
Verte Therapeutics LLC
Verte Therapeutics LLC Pharmaceuticals: MajorHealth Technology Verte Therapeutics LLC offers cardio health related services. The private company is based in Wilmington, DE. | Directeur/Membre du Conseil | - |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Directeur/Membre du Conseil | 24/06/2019 |
Anciens postes connus de Craig Tooman
Sociétés | Poste | Fin |
---|---|---|
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Directeur Financier/CFO | 01/01/2021 |
INSITE VISION INC. | Directeur/Membre du Conseil | 02/11/2015 |
Avanzar Medical, Inc.
Avanzar Medical, Inc. Medical/Nursing ServicesHealth Services Avanzar Medical, Inc. operates an oncology clinic. The private company is based in Dallas, TX. | Directeur Général | 01/11/2014 |
░░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Craig Tooman
The University of Chicago | Masters Business Admin |
Kalamazoo College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
ENZON PHARMACEUTICALS, INC. | Health Technology |
ONDINE BIOMEDICAL INC. | Health Technology |
SILENCE THERAPEUTICS PLC | Commercial Services |
CUREVAC N.V. | Health Technology |
Entreprise privées | 16 |
---|---|
InSite Vision, Inc.
InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology InSite Vision Inc. develops and markets ophthalmic pharmaceutical products that designs to treat a range of common eye problems, including ocular infection, pain and inflammation in ocular surgery, and glaucoma. Its products include AzaSite, Besivance, AzaSite Plus, DexaSite, AzaSite Xtra, and ISV-10 and 303. The company was founded by Merwin Jerry Hansen in 1986 and is headquartered in Alameda, CA. | Health Technology |
Pharmacia & Upjohn, Inc. | Health Technology |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
Ikaria, Inc.
Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Aratana Therapeutics, Inc.
Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Xanodyne Pharmaceuticals, Inc.
Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Health Technology |
Aratana Therapeutics NV
Aratana Therapeutics NV Pharmaceuticals: OtherHealth Technology Aratana Therapeutics NV engages in the development and marketing of veterinary medicine. It offers Entyce, nocita, and Galliprant. The company was founded on December 20, 2007 and is headquartered in Leuven, Belgium. | Health Technology |
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Health Technology |
Avanzar Medical, Inc.
Avanzar Medical, Inc. Medical/Nursing ServicesHealth Services Avanzar Medical, Inc. operates an oncology clinic. The private company is based in Dallas, TX. | Health Services |
Stockbourne LLC | |
Vet Therapeutics, Inc.
Vet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Vet Therapeutics, Inc. develops antibodies and pharmaceutical products for animals. The company is based in Del Mar, CA. Vet Therapeutics was acquired by Aratana Therapeutics, Inc., part of Elanco Animal Health, Inc. from July 19, 2019 on October 16, 2013 for $55.29 million. | Health Technology |
ViroVet NV
ViroVet NV Pharmaceuticals: MajorHealth Technology ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation. | Health Technology |
Silence Therapeutics, Inc. | |
Verte Therapeutics LLC
Verte Therapeutics LLC Pharmaceuticals: MajorHealth Technology Verte Therapeutics LLC offers cardio health related services. The private company is based in Wilmington, DE. | Health Technology |